Citations 437

Etiologies of Myelopathy in Uganda Based on Neuroimaging, Autoantibodies, and Next Generation Sequencing (S4.008)

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000206108

Identification of Calcium Dysregulation in Immune-mediated Rippling Muscle Disease (P8-11.001)

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000206010

Investigating Radiological Lag and the Temporal Evolution of MRI Lesions Within the Same Attack in MOGAD (S32.008)

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000205834

Defining the CSF Cytokine and Chemokine Signature of Neurosarcoidosis (S38.009)

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000205790

Isolated Meningitis Is a Unique Clinical Phenotype of Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (P9-14.003)

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000205621

Residual Symptoms, Recovery & Predictors of Long-term Sequalae After Autoimmune Encephalitis (S4.003)

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000205399

Evaluation of the Diagnostic Utility of Caveolae-associated Protein 4 (cavin-4) Epitope-based ELISA in Identification of Immune Mediated Rippling Muscle Disease (S38.003)

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000204917

Late Relapse After Prolonged Remission Post-autologous Hematopoietic Stem Cell Transplantation in Two Patients with AQP4-IgG+ Neuromyelitis Optica Spectrum Disorder (P11-14.001)

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000204806

CAMKV Autoimmune Paraneoplastic Encephalitis (N1.003)

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000204736

Indirect Treatment Comparison of Ravulizumab Versus Approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-Positive (AQP4-IgG+) Neuromyelitis Optica Spectrum Disorder (NMOSD) (P10-14.005)

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000204578